Chiara Pozzato

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Dna Damage Response

Cell Proliferation

Top Venues

Cancer research communications

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-associated purine synthesis pathway is a major component of the MET-DNA damage response network. Cancer research communications (2024)
Chiara Pozzato, Gonçalo Outeiro-Pinho, Mirco Galiè, Giorgio Ramadori, Georgia Konstantinidou
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer. EMBO molecular medicine (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)